NFKB1 and ischemic stroke: Furthermore, given the established role of FKBP51 in NF-κB pathway-mediated immune inflammation, its increased expression can amplify inflammation and cardiovascular risk by activating the master immune regulator NF-κB, thereby exacerbating the pro-inflammatory environment in ischemic stroke (Zannas et al., 2019).